Sphingosine 1-Phosphate, Present in Serum-derived Lipoproteins, Activates Matriptase*

We describe here a novel biological function of sphingosine 1-phosphate (S1P): the activation of a serine protease, matriptase. Matriptase is a type II integral membrane serine protease, expressed on the surface of a variety of epithelial cells; it may play an important role in tissue remodeling. We have previously reported that the activation of matriptase is regulated by serum. We have now identified the bioactive component from serum. First, the activity was observed to co-purify with lipoproteins by conventional liquid chromatography and immunoaffinity chromatography. The ability of lipoproteins to induce the activation of matriptase was further confirmed with commercial preparations of low density lipoprotein (LDL) and very low density lipoprotein (VLDL). Next, we observed that the bioactive component of LDL is associated with the phospholipid components of LDL. Fractionation of lipid components of LDL by thin layer chromatography (TLC) revealed that the bioactive component of LDL comigrates with S1P. Nanomolar concentrations of commercially obtained S1P were then observed to induce the rapid activation of matriptase on the surfaces of nontransformed human mammary epithelial cells. Other structurally related sphingolipids, including dihydro-S1P, ceramide 1-phosphates, and sphingosine phosphocholine as well as lysophosphatidic acid, can also induce the activation of matriptase, but at significantly higher concentrations than S1P. Furthermore, S1P-dependent matriptase activation is dependent on Ca2+ but not via Gi protein-coupled receptors. Our results demonstrate that bioactive phospholipids can function as nonprotein activators of a cell surface protease, suggesting a possible mechanistic link between S1P and normal and possibly pathologic tissue remodeling.

[1]  S. Pyne,et al.  Sphingosine 1-phosphate signalling in mammalian cells , 2000 .

[2]  S. Spiegel,et al.  Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositol trisphosphate-independent pathway. , 1994, The Journal of biological chemistry.

[3]  T. Hla,et al.  Differential Pharmacological Properties and Signal Transduction of the Sphingosine 1-Phosphate Receptors EDG-1, EDG-3, and EDG-5* , 1999, The Journal of Biological Chemistry.

[4]  W. Schneider-Brachert,et al.  Cathepsin D targeted by acid sphingomyelinase‐derived ceramide , 1999, The EMBO journal.

[5]  T. Hla,et al.  Lysophosphatidic Acid Stimulates the G-protein-coupled Receptor EDG-1 as a Low Affinity Agonist* , 1998, The Journal of Biological Chemistry.

[6]  R. Dickson,et al.  Activation of Hepatocyte Growth Factor and Urokinase/Plasminogen Activator by Matriptase, an Epithelial Membrane Serine Protease* , 2000, The Journal of Biological Chemistry.

[7]  R. Dickson,et al.  Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. , 2001, European journal of biochemistry.

[8]  V. Schumaker,et al.  Activation of the first component of complement. , 1987, Annual review of immunology.

[9]  T. Borsós,et al.  Distinction between fixation of C1 and the activation of complement by natural IgM anti-hapten antibody: effect of cell surface hapten density. , 1981, Molecular immunology.

[10]  Y. Yatomi,et al.  EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16. , 1999, Biochemical and biophysical research communications.

[11]  Ingrid,et al.  Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1. , 1998, The Biochemical journal.

[12]  T. Yoneya,et al.  Edg-6 as a putative sphingosine 1-phosphate receptor coupling to Ca(2+) signaling pathway. , 2000, Biochemical and biophysical research communications.

[13]  W. Stetler-Stevenson,et al.  Proteases in invasion: matrix metalloproteinases. , 2001, Seminars in cancer biology.

[14]  R. Dickson,et al.  Roles of the matrix metalloproteinases in mammary gland development and cancer , 1998, Breast Cancer Research and Treatment.

[15]  T. Hla,et al.  The Inducible G Protein-coupled Receptor edg-1 Signals via the G/Mitogen-activated Protein Kinase Pathway (*) , 1996, The Journal of Biological Chemistry.

[16]  S. Milstien,et al.  Sphingosine‐1‐phosphate: signaling inside and out , 2000, FEBS letters.

[17]  C. Craik,et al.  Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Barr,et al.  Differential Coupling of the Sphingosine 1-Phosphate Receptors Edg-1, Edg-3, and H218/Edg-5 to the Gi, Gq, and G12 Families of Heterotrimeric G Proteins* , 1999, The Journal of Biological Chemistry.

[19]  Y. Yatomi,et al.  EDG1 Is a Functional Sphingosine-1-phosphate Receptor That Is Linked via a Gi/o to Multiple Signaling Pathways, Including Phospholipase C Activation, Ca2+Mobilization, Ras-Mitogen-activated Protein Kinase Activation, and Adenylate Cyclase Inhibition* , 1998, The Journal of Biological Chemistry.

[20]  C. Strader,et al.  Identification of allosteric antagonists of receptor-guanine nucleotide-binding protein interactions. , 1990, Molecular Pharmacology.

[21]  R. Schwartz,et al.  Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains , 1999, Immunogenetics.

[22]  S. Spiegel,et al.  Sphingosine 1-Phosphate-induced Cell Rounding and Neurite Retraction Are Mediated by the G Protein-coupled Receptor H218* , 1999, The Journal of Biological Chemistry.

[23]  T. Hla.  Sphingosine 1-phosphate receptors. , 2001, Prostaglandins & other lipid mediators.

[24]  L. Baudhuin,et al.  Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1 , 2000, Nature Cell Biology.

[25]  M. Aepfelbacher,et al.  Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Johnson,et al.  Purification and Characterization of a Complex Containing Matriptase and a Kunitz-type Serine Protease Inhibitor from Human Milk* , 1999, The Journal of Biological Chemistry.

[27]  S. Spiegel,et al.  Sphingosine 1-phosphate stimulates rho-mediated tyrosine phosphorylation of focal adhesion kinase and paxillin in Swiss 3T3 fibroblasts. , 1997, The Biochemical journal.

[28]  R. Dickson,et al.  Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. , 2001, The American journal of pathology.

[29]  S. Pyne,et al.  Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors. , 2000, Pharmacology & therapeutics.

[30]  O. Witte,et al.  Sphingosylphosphorylcholine and Lysophosphatidylcholine Are Ligands for the G Protein-coupled Receptor GPR4* , 2001, The Journal of Biological Chemistry.

[31]  S. Spiegel,et al.  Sphingosine Kinase Expression Increases Intracellular Sphingosine-1-Phosphate and Promotes Cell Growth and Survival , 1999, The Journal of cell biology.

[32]  R. Dickson,et al.  Characterization of a Novel, Membrane-bound, 80-kDa Matrix-degrading Protease from Human Breast Cancer Cells , 1997, The Journal of Biological Chemistry.

[33]  S. Spiegel,et al.  Dual Actions of Sphingosine-1-Phosphate: Extracellular through the Gi-coupled Receptor Edg-1 and Intracellular to Regulate Proliferation and Survival , 1998, The Journal of cell biology.

[34]  C. H. Liu,et al.  Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. , 1998, Science.

[35]  Jennifer L. Harris,et al.  Cellular Localization of Membrane-type Serine Protease 1 and Identification of Protease-activated Receptor-2 and Single-chain Urokinase-type Plasminogen Activator as Substrates* , 2000, The Journal of Biological Chemistry.

[36]  M. Johnson,et al.  Molecular Cloning of cDNA for Matriptase, a Matrix-degrading Serine Protease with Trypsin-like Activity* , 1999, The Journal of Biological Chemistry.

[37]  T. Ishizuka,et al.  Comparison of Intrinsic Activities of the Putative Sphingosine 1-Phosphate Receptor Subtypes to Regulate Several Signaling Pathways in Their cDNA-transfected Chinese Hamster Ovary Cells* , 1999, The Journal of Biological Chemistry.

[38]  S. Spiegel,et al.  Enzymatic measurement of sphingosine 1-phosphate. , 1999, Analytical biochemistry.

[39]  B. O'dowd,et al.  Characterization of a Novel Sphingosine 1-Phosphate Receptor, Edg-8* , 2000, The Journal of Biological Chemistry.